Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …

Dementia with Lewy bodies is the second most common form of neurodegenerative
dementia, yet scarce evidence is available about its prognosis and natural history, which are …

Abstract Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD), which share many clinical, neurochemical, and morphological features, have been …

Deep learning (DL) methods have in recent years yielded impressive results in medical
imaging, with the potential to function as clinical aid to radiologists. However, DL models in …

Purpose The purpose of this study is to develop and validate a 3D deep learning model that
predicts the final clinical diagnosis of Alzheimer's disease (AD), dementia with Lewy bodies …

Lewy bodies were first discovered in neurons by the German neurologist Dr Friedrich Lewy
in 1912 while he was studying the neuropathology of Parkinson disease (PD) in the …

Importance Plasma phosphorylated tau (p-tau) has proven to be an accurate biomarker for
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …

In this review, we summarize the current knowledge on sex differences in dementia with
Lewy bodies (DLB) relating to epidemiology, clinical features, neuropathology, biomarkers …

Neurodegenerative diseases are usually sporadic in nature and commonly influenced by a
wide range of genetic, life style and environmental factors. A unifying feature of Alzheimer's …

Objective In a multicenter cohort of probable dementia with Lewy bodies (DLB), we tested
the hypothesis that β-amyloid and tau biomarker positivity increases with age, which is …